FDA Nominee Crawford Still In Limbo; Grassley Wants More Answers
This article was originally published in The Tan Sheet
Senate Finance Committee Chairman Charles Grassley (R-Iowa) is not satisfied with FDA Commissioner nominee Lester Crawford's answers to written questions posed as part of the confirmation process
You may also be interested in...
Acting FDA Commissioner Lester Crawford's prospects for Senate confirmation appear to be in jeopardy after the Health Committee disclosed concerns about a conduct allegation lodged against the nominee
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning